Review Article
Stereotactic Hypofractionated Irradiation for Metastatic, Inoperable, and Recurrent Malignancies: A Modern Necessity, rather than a Luxury
Table 5
Evidence for the use of SABR in lymph nodal oligometastases.
| | Study | Remarks | Conclusions |
| | Bae et al. [61] | SABR for 18 patients of abdominal LN oligometastasis. | 5-year LC 57%. |
| | Choi et al. [62] | Retrospective (). SABR for isolated para-aortic LN recurrence from gynecological malignancies. | 4-year LC of 67.4%. Median time to progression of 32 months. |
| | Bignardi et al. [63] | Retroperitoneal LN () oligometastases treated with SABR. | 2-year LC of 78%. Most patients progress systemically, but local control adds to quality of life. |
| |
Jereczek-Fossa et al. [64] | Prostate cancer () with isolated LN metastases. | SABR provided 100% local control. Most patients progressed at median time of 12.7 months, but no case of in-field progression. |
|
|
LN: lymph node; LC: local control.
|
